Crinetics Pharmaceuticals, Inc. (CRNX)

NASDAQ: CRNX · IEX Real-Time Price · USD

45.54

-0.53 (-1.15%)

At close: Jul 2, 2024, 4:00 PM

45.24

-0.30 (-0.66%)

After-hours: Jul 2, 2024, 4:31 PM EDT

Crinetics Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2016
Net Income	-214.53	-163.92	-107.64	-73.81	-50.42	Upgrade
Depreciation & Amortization	2.31	1.39	1.26	1.23	1.11	Upgrade
Share-Based Compensation	40.94	28.27	17.35	10.43	6.29	Upgrade
Other Operating Activities	4.98	19.06	0.44	0.13	-3.37	Upgrade
Operating Cash Flow	-166.31	-115.21	-88.59	-62.03	-46.38	Upgrade
Capital Expenditures	-4.69	-1.66	-0.44	-0.19	-0.49	Upgrade
Acquisitions	-5	0	0	0	0	Upgrade
Change in Investments	-190.73	-172.32	-56.05	0.4	42.16	Upgrade
Investing Cash Flow	-200.41	-173.98	-56.48	0.22	41.67	Upgrade
Share Issuance / Repurchase	388.94	121.96	252.68	114.57	0.07	Upgrade
Financing Cash Flow	388.94	121.96	252.68	114.57	0.07	Upgrade
Net Cash Flow	22.22	-167.22	107.61	52.76	-4.65	Upgrade
Free Cash Flow	-171	-116.86	-89.02	-62.21	-46.87	Upgrade
Free Cash Flow Margin	-4261.03%	-2466.98%	-8258.26%	-87623.94%	-3929.00%	Upgrade
Free Cash Flow Per Share	-2.94	-2.25	-2.32	-2.04	-1.94	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).